Expand ACHV Menu
ACHV MENU

ACHV Stock Summary and Trading Ideas (Achieve Life Sciences - Common Shares | NASDAQ:ACHV)

Charts for Today's Stock Price and Implied Volatility in Achieve Life Sciences - Common Shares

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Achieve Life Sciences - Common Shares (ACHV) Frequently Asked Questions

What does Achieve Life Sciences - Common Shares do?

Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.

What symbol and exchange does Achieve Life Sciences - Common Shares shares trade?

Achieve Life Sciences - Common Shares trades on the NASDAQ stock market under the symbol ACHV.

What is Achieve Life Sciences - Common Shares stock price doing today?

As of November 16, 2026, ACHV stock price was flat at $6.78 with million shares trading.

What is Achieve Life Sciences - Common Shares's Beta?

ACHV has a beta of 3.44, meaning it tends to be more sensitive to market movements. ACHV has a correlation of 0.21 to the broad based SPY ETF.

How much is Achieve Life Sciences - Common Shares worth?

ACHV has a market cap of $699.03 million. This is considered a Small Cap stock.

What is the highest and lowest price Achieve Life Sciences - Common Shares traded in the last 3 year period?

In the last 3 years, ACHV traded as high as $8.64 and as low as $1.84.

What are the top ETFs holding Achieve Life Sciences - Common Shares?

The top ETF exchange traded funds that ACHV belongs to (by Net Assets): VTI, VXF, VTWO, VTWG, LABU.

Is Achieve Life Sciences - Common Shares (ACHV) a good investment?

ACHV has outperformed the market in the last year with a price return of +48.0% while the SPY ETF gained +11.2%. However, in the short term, ACHV had mixed performance relative to the market. It has underperformed in the last 3 months, returning -6.5% vs -4.6% return in SPY. But in the last 2 weeks, ACHV shares have fared better than the market returning -0.7% compared to SPY -2.1%.

What are the support and resistance levels for Achieve Life Sciences - Common Shares (ACHV)?

ACHV support price is $6.52 and resistance is $7.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHV shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes